Abstract:OBJECTIVE Malignant meningioma is rare and classified as Grade III in the WHO classification of CNS tumors. However, the presence of estrogen receptor (ER) in WHO Grade III meningiomas and its correlation with patients' outcomes are still unclear. In this single-center cohort study, the authors analyzed clinical features, treatment, and prognosis of these malignant tumors in patients with long-term follow-up. METHODS A total of 87 patients who were pathologically diagnosed with WHO Grade III meningiomas between 2003 and 2008 were enrolled in this study and followed for at least 7 years. Clinical information was collected to analyze the factors determining the prognosis. RESULTS Twelve patients with rhabdoid, 12 with papillary, and 63 with anaplastic meningioma were included. The mean progression-free survival (PFS) and overall survival (OS) were 56.2 +/- 49.8 months and 68.7 +/- 47.4 months, respectively. No significant differences were observed among the 3 histological subtypes in either PFS (p = 0.929) or OS (p = 0.688). Patients who received gross-total resection had a longer PFS (p = 0.001) and OS (p = 0.027) than those who received subtotal resection. Adjuvant radiotherapy was associated with OS (p = 0.034) but not PFS (p = 0.433). Compared with primary meningiomas, patients with recurrent disease had worse PFS (p < 0.001). For patients who had malignant transformations, the prognosis was poorer than for patients without malignant transformations for both PFS (p = 0.002) and OS (p = 0.019). ER-positive patients had a significantly worse prognosis than ER-negative patients regarding both PFS (p = 0.003) and OS (p < 0.001), whereas no association between progesterone receptor and patients' outcomes was observed. Multivariate analysis demonstrated that ER expression was an independent prognostic factor for both PFS (p = 0.008) and OS (p < 0.001). CONCLUSIONS This retrospective study showed that patients with meningioma with ER-positive expression had a much worse prognosis than those with ER weak-positive or ER-negative status. The results demonstrated that ER is an independent prognostic factor for both PFS and OS of patients with WHO Grade III meningioma. The authors also found that more radical resection of the tumor, as well as postoperative radiotherapy, may prolong patients' survival time.

Prognostic factors and long-term outcomes of primary intracranial rhabdoid meningioma: A systematic review

Treatment strategy and long-term outcomes of primary intracranial rhabdomyosarcoma: a single-institution experience and systematic review

Clinicopathological Analysis of Rhabdoid Meningiomas: Report of 12 Cases and a Systematic Review of the Literature.

Clinical Features and Prognostic Factors of Who Ii and Iii Adult Spinal Meningiomas: Analysis of 25 Cases in A Single Center

Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.

Prognostic Factors for Patients with World Health Organization Grade III Meningiomas Treated at a Single Center

WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index

Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes

Analysis on Therapeutic Outcomes and Prognostic Factors of Intracranial Ependymoma: A Report of 49 Clinical Cases in A Single Center

Polymeric Immunoglobulin Receptor Expression Is Predictive Of Poor Prognosis In Glioma Patients

Long-Term Outcomes of Stereotactic Radiosurgery for Postoperative World Health Organization Grade I Skull Base Meningioma: Utility of Ki-67 Labeling Index as a Prognostic Indicator

World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment

1245 Malignant Meningioma Survival, Recurrence and Functional Outcomes in an International Multicenter Cohort

Analysis of Prognostic Factors of World Health Organization Grade III Meningiomas

Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas

Skull Base Atypical Meningioma: Long Term Surgical Outcome and Prognostic Factors.

Long-term Outcomes of Multimodality Management for Parasagittal Meningiomas

Spinal meningiomas: Treatment outcome and long-term follow-up

Grade 3 meningioma survival and recurrence outcomes in an international multicenter cohort

Primary intracranial malignant melanomas: A case series with literature review

Primary Intracranial Extradural Meningiomas: A Report of 5 Cases and Literature Review